foreign antigen
(subgroup of
antigen)
→
IsA
→
pathogen
|
0.77
|
|
antigen
→
CapableOf
→
trigger immune response
|
0.74
|
|
antigen
→
CapableOf
→
bind to antibody
|
0.74
|
|
antigen
(aspect of
vaccine)
→
CapableOf
→
induce immune response
|
0.72
|
|
antigen
(aspect of
vaccine)
→
ReceivesAction
→
contained in the vaccine
|
0.69
|
|
exogenous antigen
(subgroup of
antigen)
→
CapableOf
→
enter the body
|
0.68
|
|
specific antigen
(subgroup of
antigen)
→
ReceivesAction
→
mediated by antibody
|
0.68
|
|
tumor antigen
(subgroup of
antigen)
→
ReceivesAction
→
recognized by ctl
|
0.68
|
|
antigen
→
ReceivesAction
→
detected
|
0.66
|
|
antigen
→
IsA
→
substance
|
0.64
|
|
antigen
→
CapableOf
→
trigger immune system
|
0.63
|
|
antigen
→
HasProperty
→
foreign
|
0.58
|
|
antigen
→
ReceivesAction
→
expressed
|
0.57
|
|
antigen
(aspect of
vaccine)
→
ReceivesAction
→
expressed
|
0.56
|
|
antigen
(aspect of
vaccine)
→
IsA
→
substance
|
0.55
|
|
antigen
→
HasProperty
→
protective
|
0.55
|
|
antigen
→
CapableOf
→
enter the body
|
0.55
|
|
antigen
→
HasProperty
→
absent
|
0.54
|
|
antigen
(aspect of
vaccine)
→
ReceivesAction
→
recognized
|
0.54
|
|
antigen
→
HasProperty
→
unique
|
0.54
|
|
antigen
→
HasProperty
→
effective
|
0.54
|
|
antigen
→
ReceivesAction
→
tested
|
0.53
|
|
antigen
→
CapableOf
→
reside on mammalian leukocytes
|
0.53
|
|
antigen
→
CapableOf
→
interact with specific antibodies
|
0.53
|
|
antigen
→
IsA
→
carbohydrate
|
0.53
|
|
antigen
→
HasProperty
→
immunogenic
|
0.53
|
|
antigen
→
CapableOf
→
bind to hormone
|
0.53
|
|
antigen
→
CapableOf
→
bind to enzyme
|
0.53
|
|
antigen
(aspect of
vaccine)
→
CapableOf
→
enter the body
|
0.52
|
|
antigen
→
ReceivesAction
→
recognized
|
0.52
|
|
antigen
→
ReceivesAction
→
prepared
|
0.52
|
|
antigen
→
ReceivesAction
→
targeted
|
0.52
|
|
antigen
(aspect of
vaccine)
→
HasProperty
→
immunogenic
|
0.51
|
|
antigen
(aspect of
vaccine)
→
CapableOf
→
stimulate immune system
|
0.51
|
|
vaccine
→
HasA
→
antigen
|
0.50
|
|
antigen
(aspect of
vaccine)
→
CapableOf
→
look like disease-causing organism
|
0.50
|
|
antigen
→
HasProperty
→
co
|
0.49
|
|
antigen
→
ReceivesAction
→
found on macrophage
|
0.49
|
|
antigen
→
DefinedAs
→
substance
|
0.48
|
|
antigen
→
ReceivesAction
→
processed
|
0.48
|
|
antigen
(aspect of
vaccine)
→
ReceivesAction
→
presented to immune system
|
0.48
|
|
antigen
→
HasProperty
→
specific
|
0.47
|
|
antigen
(aspect of
vaccine)
→
CapableOf
→
interact with specific antibodies
|
0.47
|
|
antigen
→
ReceivesAction
→
defined
|
0.45
|
|
antigen
(aspect of
vaccine)
→
HasProperty
→
protective
|
0.45
|
|
antigen
→
ReceivesAction
→
presented to t cells
|
0.45
|
|
antigen
→
IsA
→
foreign substance
|
0.45
|
|
antigen
→
ReceivesAction
→
found on other cells
|
0.45
|
|
antigen
(aspect of
vaccine)
→
HasProperty
→
specific
|
0.45
|
|
antigen
→
ReceivesAction
→
recognized by immune system
|
0.44
|
|
antigen
→
ReceivesAction
→
recognized by antibody
|
0.44
|
|
antigen
→
ReceivesAction
→
recognized by specific lymphocytes
|
0.44
|
|
antigen
→
ReceivesAction
→
protected by basic patent
|
0.44
|
|
antigen
→
ReceivesAction
→
found on b-lymphocytes
|
0.44
|
|
antigen
→
ReceivesAction
→
expressed by tumor cells
|
0.43
|
|
antigen
→
CapableOf
→
combine with antibody
|
0.43
|
|
antigen
→
ReceivesAction
→
determined by leukocyte loci
|
0.43
|
|
antigen
(aspect of
vaccine)
→
CapableOf
→
reside on mammalian leukocytes
|
0.42
|
|
antigen
(aspect of
vaccine)
→
ReceivesAction
→
administered for treatment
|
0.42
|
|
antigen
→
ReceivesAction
→
administered for treatment
|
0.42
|
|
antigen
→
CapableOf
→
find on immature hematopoietic cells
|
0.42
|
|
antigen
→
CapableOf
→
find on endothelial cells
|
0.42
|
|
antigen
→
CapableOf
→
express on the membranes of living cells
|
0.42
|
|
antigen
(aspect of
vaccine)
→
ReceivesAction
→
prepared
|
0.42
|
|
antigen
→
CapableOf
→
present dendritic cells
|
0.42
|
|
antigen
→
ReceivesAction
→
found on pathogen
|
0.41
|
|
antigen
→
ReceivesAction
→
amplified in rt-pcr
|
0.41
|
|
antigen
→
HasProperty
→
reactive
|
0.41
|
|
antigen
→
ReceivesAction
→
titrated
|
0.41
|
|
antigen
(aspect of
vaccine)
→
Causes
→
disease
|
0.41
|
|
antigen
→
ReceivesAction
→
expressed on b-cell precursors
|
0.41
|
|
antigen
→
ReceivesAction
→
produced
|
0.41
|
|
antigen
→
CapableOf
→
produce antibody
|
0.41
|
|
antigen
→
ReceivesAction
→
identified
|
0.41
|
|
antigen
(aspect of
vaccine)
→
HasPrerequisite
→
processing
|
0.41
|
|
antigen
→
HasProperty
→
cross
|
0.40
|
|
antigen
→
ReceivesAction
→
presented by b cells
|
0.40
|
|
antigen
→
ReceivesAction
→
found on epidermal cells
|
0.40
|
|
antigen
→
ReceivesAction
→
found on sperm
|
0.40
|
|
antigen
→
CapableOf
→
mediate the competence
|
0.40
|
|
antigen
→
CapableOf
→
mediate cellular cooperation
|
0.40
|
|
antigen
→
ReceivesAction
→
purified
|
0.40
|
|
antigen
→
ReceivesAction
→
recognized by cytolytic t lymphocytes
|
0.40
|
|
antigen
→
CapableOf
→
bind to the t-cell receptor
|
0.40
|
|
antigen
(aspect of
vaccine)
→
ReceivesAction
→
killed
|
0.39
|
|
antigen
→
ReceivesAction
→
cleared
|
0.39
|
|
antigen
→
ReceivesAction
→
found on thymocyte
|
0.39
|
|
antigen
→
CapableOf
→
stimulate the production of an antibody
|
0.38
|
|
antigen
→
HasProperty
→
the most encountered
|
0.38
|
|
antigen
→
ReceivesAction
→
presented by mhc molecules
|
0.38
|
|
antigen
→
ReceivesAction
→
presented by mhc class
|
0.37
|
|
antigen
→
ReceivesAction
→
found on the surface of neutrophils
|
0.37
|
|
antigen
→
ReceivesAction
→
presented to lymphocyte
|
0.37
|
|
antigen
→
CapableOf
→
trigger the reaction
|
0.36
|
|
antigen
→
ReceivesAction
→
filtered through lymph nodes
|
0.36
|
|
antigen
→
ReceivesAction
→
internalized
|
0.36
|
|
antigen
→
ReceivesAction
→
released
|
0.35
|
|
antigen
→
HasProperty
→
soluble
|
0.35
|
|
antigen
→
ReceivesAction
→
immobilized on solid phase
|
0.35
|
|
antigen
→
ReceivesAction
→
expressed on the cell membrane of t-lymphocytes
|
0.35
|
|
antigen
→
ReceivesAction
→
presented by dc
|
0.35
|
|
antigen
→
ReceivesAction
→
associated with autoimmune disease
|
0.35
|
|
antigen
(aspect of
vaccine)
→
CapableOf
→
bind to antibody
|
0.35
|
|
antigen
(aspect of
vaccine)
→
ReceivesAction
→
injected into the body
|
0.35
|
|
antigen
(aspect of
vaccine)
→
ReceivesAction
→
presented to lymphocyte
|
0.35
|
|
antigen
(aspect of
vaccine)
→
ReceivesAction
→
remembered by immune system
|
0.35
|
|
antigen
→
HasProperty
→
abundant
|
0.35
|
|
antigen
→
CapableOf
→
comprise one or more epitopes
|
0.34
|
|
antigen
→
CapableOf
→
express on mature t-cells
|
0.34
|
|
antigen
→
ReceivesAction
→
used in elisa
|
0.34
|
|
antigen
→
ReceivesAction
→
associated with tumor
|
0.34
|
|
antigen
→
ReceivesAction
→
used in allergy drops
|
0.34
|
|
antigen
→
HasA
→
a synthetic peptide sequence
|
0.34
|
|
antigen
(aspect of
vaccine)
→
HasProperty
→
foreign
|
0.34
|
|
antigen
→
Causes
→
disease
|
0.33
|
|
antigen
→
ReceivesAction
→
presented by apc
|
0.33
|
|
antigen
→
ReceivesAction
→
introduced by vaccine
|
0.33
|
|
antigen
→
CapableOf
→
differentiation major platelet membrane glycoproteins
|
0.33
|
|
antigen
→
CapableOf
→
exist in alternative allelicforms
|
0.33
|
|
antigen
→
CapableOf
→
exist in single species
|
0.33
|
|
antigen
→
ReceivesAction
→
found on normal human monocytes
|
0.33
|
|
antigen
→
ReceivesAction
→
found on granulocyte
|
0.33
|
|
antigen
(aspect of
vaccine)
→
ReceivesAction
→
used in the uk
|
0.32
|
|
antigen
(aspect of
vaccine)
→
CapableOf
→
tell body’s immune system
|
0.32
|
|
antigen
(aspect of
vaccine)
→
ReceivesAction
→
delivered
|
0.32
|
|
antigen
(aspect of
vaccine)
→
ReceivesAction
→
involved in allergy
|
0.32
|
|
antigen
→
CapableOf
→
enter the bloodstream
|
0.32
|
|
antigen
→
ReceivesAction
→
recognized by cd4
|
0.32
|
|
antigen
→
ReceivesAction
→
recognized on human melanomas
|
0.32
|
|
antigen
(aspect of
vaccine)
→
HasProperty
→
useful
|
0.31
|
|
antigen
→
ReceivesAction
→
conserved
|
0.30
|
|
antigen
→
ReceivesAction
→
allowed to react with the serum
|
0.30
|
|
antigen
→
CapableOf
→
precipitate using protein a sepharose beads
|
0.30
|
|
antigen
(aspect of
vaccine)
→
CapableOf
→
mediate the competence
|
0.29
|
|
antigen
(aspect of
vaccine)
→
CapableOf
→
mediate cellular cooperation
|
0.29
|
|
antigen
(aspect of
vaccine)
→
CapableOf
→
bind to the t-cell receptor
|
0.29
|
|
antigen
(aspect of
vaccine)
→
CapableOf
→
express on the membranes of living cells
|
0.29
|
|
antigen
(aspect of
vaccine)
→
ReceivesAction
→
released
|
0.29
|
|
antigen
(aspect of
vaccine)
→
ReceivesAction
→
found on b-lymphocytes
|
0.29
|
|
antigen
(aspect of
vaccine)
→
ReceivesAction
→
found on macrophage
|
0.29
|
|
antigen
(aspect of
vaccine)
→
ReceivesAction
→
found on epidermal cells
|
0.29
|
|
antigen
(aspect of
vaccine)
→
ReceivesAction
→
found on sperm
|
0.29
|
|
antigen
(aspect of
vaccine)
→
ReceivesAction
→
found on thymocyte
|
0.29
|
|
antigen
(aspect of
vaccine)
→
ReceivesAction
→
determined by leukocyte loci
|
0.29
|
|
antigen
→
HasProperty
→
free
|
0.28
|
|
antigen
→
ReceivesAction
→
tagged by antibody
|
0.28
|
|
antigen
→
ReceivesAction
→
killed
|
0.28
|
|
antigen
→
CapableOf
→
bind to receptor
|
0.28
|
|
antigen
→
ReceivesAction
→
recognized by ctl
|
0.28
|
|
antigen
→
HasProperty
→
sensitive
|
0.28
|
|
antigen
→
ReceivesAction
→
digested
|
0.28
|
|
antigen
→
ReceivesAction
→
expressed on human red blood cells
|
0.28
|
|
antigen
→
ReceivesAction
→
expressed on normoblast
|
0.28
|
|
antigen
→
ReceivesAction
→
expressed on erythroid precursor cells
|
0.28
|
|
antigen
→
CapableOf
→
belong to stage-specific ones
|
0.28
|
|
antigen
→
Causes
→
allergy
|
0.28
|
|
antigen
→
ReceivesAction
→
presented to spleen
|
0.28
|
|
antigen
→
ReceivesAction
→
presented to tonsil
|
0.28
|
|
antigen
→
ReceivesAction
→
presented to bone marrow
|
0.28
|
|
antigen
→
ReceivesAction
→
presented to thymus
|
0.28
|
|
antigen
→
CapableOf
→
bind to bcr
|
0.28
|
|
antigen
→
UsedFor
→
antibody selection
|
0.28
|
|
antigen
→
HasProperty
→
strong
|
0.28
|
|
antigen
→
ReceivesAction
→
used to immunize the animal
|
0.28
|
|
antigen
→
ReceivesAction
→
associated with synadenium carinatum latex lectin
|
0.28
|
|
antigen
→
ReceivesAction
→
immobilized on the surface of the waveguide
|
0.28
|
|
antigen
→
MadeOf
→
pullorum-typhoid bacteria
|
0.28
|
|
antigen
→
HasProperty
→
stable
|
0.28
|
|
antigen
→
ReceivesAction
→
added
|
0.26
|
|
antigen
→
ReceivesAction
→
delivered
|
0.25
|
|
antigen
→
ReceivesAction
→
broken down into peptide
|
0.25
|
|
antigen
→
ReceivesAction
→
identified by monoclonal antibody ki-67
|
0.25
|
|
antigen
→
CapableOf
→
stimulate b cells
|
0.25
|
|
antigen
→
CapableOf
→
express on platelet
|
0.25
|
|
antigen
→
CapableOf
→
bind to class
|
0.25
|
|
antigen
→
ReceivesAction
→
expressed in prostate cancer tissue
|
0.25
|
|
antigen
→
ReceivesAction
→
linked to granulocyte-macrophage colony-stimulating factor
|
0.25
|
|
antigen
→
ReceivesAction
→
endocytosed
|
0.25
|
|
antigen
→
ReceivesAction
→
generated by hypercholesterolemia
|
0.25
|
|
antigen
→
CapableOf
→
convey in the lymph
|
0.25
|
|
antigen
→
CapableOf
→
percolate through the sinusesand
|
0.25
|
|
antigen
→
CapableOf
→
penetrate the lymph nodules
|
0.25
|
|
antigen
→
ReceivesAction
→
produced by adult heartworms
|
0.25
|
|
antigen
→
CapableOf
→
bring to the surface of the cell
|
0.25
|
|
antigen
→
ReceivesAction
→
injected into chicken
|
0.25
|
|
antigen
→
ReceivesAction
→
precipitated by antibody
|
0.25
|
|
antigen
→
ReceivesAction
→
contained in boostrix
|
0.25
|
|
antigen
→
HasA
→
at least two antigenic sites
|
0.25
|
|
antigen
→
Causes
→
migraine
|
0.25
|
|
antigen
→
ReceivesAction
→
characterised by restricted tissue distribution
|
0.25
|
|
antigen
→
CapableOf
→
comprise a pcd activation peptide
|
0.25
|
|
antigen
→
CapableOf
→
activate t cells
|
0.25
|
|
antigen
→
ReceivesAction
→
used in the conjugate test
|
0.25
|
|
antigen
→
ReceivesAction
→
retained in the well
|
0.25
|
|
antigen
→
ReceivesAction
→
purified to homogeneity
|
0.25
|
|
antigen
→
CapableOf
→
bind to ag-specific receptors
|
0.25
|
|
antigen
→
CapableOf
→
bind variable immunoreceptor products
|
0.25
|
|
antigen
→
ReceivesAction
→
presented by hla class
|
0.25
|
|
antigen
→
ReceivesAction
→
taken up by dc
|
0.25
|
|
antigen
→
HasProperty
→
extrinsic
|
0.25
|
|
antigen
→
HasProperty
→
complementary
|
0.25
|
|
antigen
→
ReceivesAction
→
denatured
|
0.25
|
|
antigen
→
CapableOf
→
trigger response
|
0.25
|
|
antigen
→
ReceivesAction
→
internalized by the phagocyte
|
0.25
|
|
antigen
→
HasProperty
→
large
|
0.25
|
|
antigen
→
CapableOf
→
bind to tcr
|
0.25
|
|
antigen
→
ReceivesAction
→
taken up by the langerhans cells
|
0.25
|
|
antigen
→
ReceivesAction
→
caused to migrate in electric field
|
0.25
|
|
antigen
→
ReceivesAction
→
to be determined in given liquid sample
|
0.25
|
|
antigen
→
ReceivesAction
→
incorporated
|
0.25
|
|
antigen
→
ReceivesAction
→
coupled to solid phase
|
0.25
|
|
antigen
→
ReceivesAction
→
combined with adjuvant
|
0.25
|
|
antigen
→
ReceivesAction
→
inoculated
|
0.25
|
|
antigen
→
HasProperty
→
intrinsic
|
0.25
|
|
antigen
(aspect of
vaccine)
→
CapableOf
→
exist in alternative allelicforms
|
0.25
|
|
antigen
(aspect of
vaccine)
→
CapableOf
→
exist in single species
|
0.25
|
|
antigen
(aspect of
vaccine)
→
CapableOf
→
bind to hormone
|
0.25
|
|
antigen
(aspect of
vaccine)
→
CapableOf
→
act as target
|
0.25
|
|
antigen
(aspect of
vaccine)
→
HasProperty
→
the most encountered
|
0.25
|
|
antigen
(aspect of
vaccine)
→
HasProperty
→
absent
|
0.25
|
|
antigen
(aspect of
vaccine)
→
HasProperty
→
strong
|
0.25
|
|
antigen
(aspect of
vaccine)
→
ReceivesAction
→
purified in successive chromatographic and precipitation steps
|
0.25
|
|
antigen
(aspect of
vaccine)
→
ReceivesAction
→
contained in boostrix
|
0.25
|
|
antigen
(aspect of
vaccine)
→
ReceivesAction
→
used in method
|
0.25
|
|
antigen
(aspect of
vaccine)
→
ReceivesAction
→
purified
|
0.25
|
|
antigen
(aspect of
vaccine)
→
ReceivesAction
→
purified to homogeneity
|
0.25
|
|
antigen
(aspect of
vaccine)
→
ReceivesAction
→
encountered via oral route
|
0.25
|
|
antigen
(aspect of
vaccine)
→
ReceivesAction
→
altered
|
0.25
|
|
antigen
(aspect of
vaccine)
→
ReceivesAction
→
associated with cancer
|
0.25
|
|
antigen
(aspect of
vaccine)
→
ReceivesAction
→
targeted by the vaccine
|
0.25
|
|
antigen
(aspect of
vaccine)
→
CapableOf
→
weaken to the point
|
0.23
|
|
antigen
→
CapableOf
→
weaken to the point
|
0.23
|
|
antigen
→
PartOf
→
the host
|
0.22
|
|
antigen
→
HasProperty
→
seroreactive
|
0.21
|
|
antigen
(aspect of
vaccine)
→
ReceivesAction
→
contained in all five
|
0.20
|
|
antigen
(aspect of
vaccine)
→
ReceivesAction
→
involved in autoimmune disease
|
0.20
|
|
antigen
→
DefinedAs
→
foreign and potentially harmful invader
|
0.19
|
|
antigen
→
HasProperty
→
safe
|
0.19
|
|
antigen
→
CapableOf
→
cause tissue damage
|
0.16
|
|
antigen
→
Causes
→
pain
|
0.16
|
|
antigen
→
CapableOf
→
bind to antigen-coated well
|
0.16
|
|
antigen
→
ReceivesAction
→
used in assay
|
0.16
|
|
antigen
→
HasProperty
→
time-consuming
|
0.16
|
|
antigen
→
ReceivesAction
→
associated with pathogen
|
0.16
|
|
antigen
→
HasProperty
→
weak
|
0.16
|
|
antigen
(aspect of
vaccine)
→
CapableOf
→
enter the dog's body
|
0.16
|
|
antigen
(aspect of
vaccine)
→
HasSubevent
→
immune suppression
|
0.16
|
|
antigen
(aspect of
vaccine)
→
ReceivesAction
→
involved in graft rejection
|
0.16
|
|
antigen
→
ReceivesAction
→
discovered
|
0.15
|
|